Skip to content

Lipocine Inc.

LPCN

CIK 0001535955

← back to feed
Revenue (TTM)
$500K
−96.9% YoY Q1 May 2026
Net Income (TTM)
−$10.93M
−115,371.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.89
+46.2% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-2,341.0%
Q1 May 2026
Net Margin
-2,185.9%
Q1 May 2026
Free Cash Flow (TTM)
−$5.82M
Q1 May 2026
Cash
$5.02M
Q1 May 2026
Total Debt
$2.92M
Q1 May 2026
Shares Outstanding
8.24M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings